Received Jan 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
My wife and I both had short lived minor soreness at the injection site/the patient had short lived minor soreness at the injection site; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient received Shingles vaccine. The patient experienced injection site pain (Verbatim: My wife and I both had short lived minor soreness at the injection site). The outcome of the injection site pain was not reported. It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine. It was unknown if the company considered the injection site pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date:08-JAN-2026 This case was reported by a patient via interactive digital media. The batch number was not provided, and we are unable to contact the reporter. The case has been linked with case US2026AMR002458, reported by same reporter.; Sender's Comments: US-GSK-US2026AMR002458:SAME REPORTER